首页> 外文OA文献 >Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji)

【2h】

Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji)

机译：I型肝素辅因子II缺乏的分子和细胞基础（肝素Cofactor II AWAJI）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S Kondo; F Tokunaga; K Kario; T Matsuo; T Koide;
展开▼
作者单位

展开▼
年度 1996
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II. [J] . Mascellani G, Liverani L, Parma B, Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 1996,第1期

机译：低分子量硫酸皮肤素中肝素辅因子II的活性位点。对肝素辅因子II具有高亲和力的馏分的抗血栓活性做出了贡献。
2. Molecular mechanism of type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation at reactive P2 site: HC II Tokushima. [J] . Kanagawa Y, Shigekiyo T, Aihara K, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2001,第1期

机译：由反应性P2位点的错义突变引起的I型先天性肝素辅因子（HC）II缺乏的分子机制：HC II Tokushima。
3. Sulfated polysaccharide from the leaves of Artemisia Princeps activates heparin cofactor II independently of the Lys173 and Arg189 residues of heparin cofactor II. [J] . Hayashi T, Hayakawa Y, Hayashi T, Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 1997,第1期

机译：来自青蒿叶片的硫酸化多糖可独立于肝素辅因子II的Lys173和Arg189残基激活肝素辅因子II。
4. Interaction of antithrombin III-binding domain in heparins with novel heparin binding peptides [C] . Satomi Onoue, Yoshitaka Nemoto, Takahiro Mizumoto, the International Peptide Symposium . 2001

机译：肝素III结合结构域与新型肝素结合肽的抗凝血酶III结合结构域的相互作用
5. Antithrombin III residue tyrosine-131 serves as a molecular switch during heparin-mediated conformational activation of its anticoagulant activity. [D] . dela Cruz, Richard Glenn Cua. 2006

机译：抗凝血酶III残基酪氨酸131在肝素介导的抗凝活性构象活化过程中充当分子开关。
6. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II. [O] . R E Hurst, M C Poon, M J Griffith 1983

机译：肝素的构效关系。肝素电荷密度和抗凝血酶结合域在抗凝血酶和肝素辅因子II抑制凝血酶方面的独立性。
7. Effects of Dermatan Sulfate, a Heparin Cofactor II Mediated Thrombin Inhibitor, on the Endotoxin-Induced Disseminated Intravascular Coagulation Model in the Rat: Comparison With Low-Molecular Weight Heparin, Nafamostat Mesilate and Argathroban [O] . Junichi Onaya, Mamoru Kyogashima, Atsuko Sunose, 1998

机译：一种硫酸皮肤蛋白，肝素Cofactor II介导的凝血酶抑制剂对大鼠内毒素诱导的血管内血管凝固模型的影响：与低分子量肝素，Nafamostat介质和奥氏蛋白的比较
8. ISOLATE AND TEST HUMAN ANTITHROMBIN-III (HEPARIN COFACTOR) [R] . Grant H. Barlow, Wm. H. Holleman, Donald Martin 1977

机译：分离和测试人类抗血栓素III（HEpaRIN COFaCTOR）

Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji)

著录项

引文网络

相似文献

相关主题

期刊订阅